Access Pharmaceuticals Announces Positive ProLindac(TM) Phase 2 Ovarian Cancer Clinical Trial Results

ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), announced positive safety and efficacy results from its Phase 2 monotherapy clinical study of ProLindac(TM) in late-stage, heavily pretreated ovarian cancer patients. In this monotherapy study 66% of patients who received the highest dose achieved clinically meaningful disease stabilization according to RECIST criteria. No patient in any dose group exhibited […]

Stress May Raise Diabetes Risk for Obese Black Women

Surge in anxiety-linked hormone worsens blood sugar level, researchers suggest Stress may play a key role in the development of type 2 diabetes in obese black women, U.S. researchers say. “Much attention has been given to the role of obesity in the development of type 2 diabetes, but stress may be as important in this […]

Bad Marriages Harder on Women’s Health

More likely than mates to show signs of metabolic syndrome in strained unions, study finds The cardiovascular damage wrought by an unhappy marriage may be greater for women than men, a new study shows. While both men and women in “strained” unions, those marked by arguing and being angry, were more likely to feel depressed […]

Alcohol Consumption May Increase Pancreatic Cancer Risk

Consuming two or more drinks per day could increase a person’s risk of pancreatic cancer by about 22 percent, according to data published in Cancer Epidemiology, Biomarkers and Prevention a journal of the American Association for Cancer Research. “Our findings support multiple nutrition recommendations that men should limit intake to no more than two alcoholic […]

Wine May Be Protective Against Esophageal Cancer

One glass a day may lower risk for Barrett’s, a precursor to disease, study finds Drinking a glass of wine a day may lower the risk of Barrett’s esophagus, a condition that precedes esophageal cancer. Barrett’s esophagus, which affects about 5 percent of the population, occurs when heartburn or acid reflux permanently damages the lining […]

Bone Drug May Help Fight Breast Cancer As Part Of Therapy

Researchers from Austria and Germany found that adding the bone drug zoledronic acid to endocrine therapy improved disease-free survival in premenopausal women with early stage breast cancer of the estrogen-responsive type. The research was the work of lead author Dr Michael Gnant of the Medical University of Vienna in Austria and colleagues from other research […]

Although Pregnancy Can Delay Diagnosis And Treatment, It Has No Impact On Breast Cancer

A new study finds women who develop breast cancer while pregnant or soon afterwards do not experience any differences in disease severity or likelihood of survival compared to other women with breast cancer. The study is published in the March 15, 2009 issue of CANCER, a peer-reviewed journal of the American Cancer Society. So-called pregnancy-associated […]

Studies Released At Cancer Disparities Conference Examine Women’s Health Issues

The following summarizes news coverage of women’s health-related studies presented last week at the American Association for Cancer Research’s Science of Cancer Health Disparities conference in Carefree, Ariz. ~ HPV vaccine: Only one in four eligible black girls has received the human papillomavirus vaccine Gardasil, although most of the black community believes that the vaccine […]

Drink a Day Increases Cancer Risk

A glass of wine each evening is enough to increase your risk of developing cancer, women are being warned. Consuming just one drink a day causes an extra 7,000 cancer cases – mostly breast cancer – in UK women each year, Cancer Research UK scientists say. The risk goes up the more you drink, whether […]

Drinking Raises Cancer Risk for Middle Age Women

Research involving more than a million middle-age women finds that even moderate drinking raises risks for breast, liver and other cancers. “Even relatively low levels of drinking — on the order of one alcoholic drink per day — increase a woman’s risk of developing cancer,” said lead researcher Naomi Allen, from the cancer epidemiology unit […]